drugset / Trial / NCT07610395
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduce the severity and/or duration of respiratory symptoms associated with RV infections in patients with COPD.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2027-11-15
- Completion
- 2027-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vapendavir | Small molecule | 500 mg | Oral |
| Subject | Vapendavir | Small molecule | 1000 mg | Oral |